查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786334

全球覆膜支架市場

Covered Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 270 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球覆膜支架市場規模將達到 14 億美元

全球覆膜支架市場規模預計在2024年為11億美元，到2030年將達到14億美元，在分析期間（2024-2030年）的複合年成長率為3.3%。血管支架是本報告分析的細分市場之一，預計其複合年成長率為3.9%，到分析期結束時將達到9.917億美元。非血管支架市場在分析期間內的複合年成長率預計為1.9%。

美國市場規模估計為 3.109 億美元，中國市場預計複合年成長率為 6.3%

預計2024年，美國覆膜支架市場規模將達到3.109億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到2.759億美元，在2024-2030年的分析期間內，複合年成長率為6.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.2%和2.5%。在歐洲，預計德國市場的複合年成長率為1.9%。

全球覆膜支架市場－主要趨勢與促進因素摘要

覆膜支架為何廣泛採用？介入心臟病學的快速成長

由於心血管疾病、周邊動脈疾病(PAD) 和動脈瘤的發生率不斷上升，全球覆膜支架市場正在經歷顯著成長。隨著越來越多的患者需要微創血管介入治療，覆膜支架已成為重要的醫療設備，能夠有效預防血管再阻塞和破裂。老化人口的不斷成長，使得動脈阻塞和動脈瘤的風險更高，這進一步推動了市場需求。此外，藥物釋放型和生物可吸收支架等支架技術的進步改善了治療效果，使其成為介入性心臟病專家的首選。從開放性手術到導管介入的轉變正在推動市場擴張，因為覆膜支架為複雜的血管手術提供了微創替代方案。人們對動脈疾病早期診斷和治療的認知不斷提高以及醫療支出的不斷增加，也在市場成長中發揮關鍵作用。政府倡導心血管健康的舉措以及篩檢計畫的不斷增加，進一步加速了覆膜支架的普及。

覆膜支架主要有哪些種類？按材料和應用細分市場

覆膜支架市場根據材料成分、設計和應用進行細分，每種市場都針對特定的醫療需求。 PTFE（聚四氟乙烯）和ePTFE塗層支架因其生物相容性、靈活性和最大限度減少血管再阻塞的能力而應用最廣泛。聚氨酯塗層支架是另一種主流支架，以其耐用性和抗血栓形成而聞名。覆膜支架廣泛用於心血管應用，特別是用於治療主動脈瘤和冠狀動脈疾病。周邊血管應用，包括頸動脈和股動脈的治療，也正在得到越來越多的採用。此外，覆膜支架在內視鏡介入治療中發揮重要作用，特別是在膽道阻塞和胃腸道疾病的治療中。自膨脹和球囊擴張型覆膜支架的發展進一步豐富了治療選擇，使醫生能夠根據患者獨特的血管狀況選擇最佳設備。混合支架設計（將金屬支架與生物可吸收聚合物塗層結合）的日益普及也促進了市場的成長。

創新如何推動覆膜支架的未來？生物工程與智慧支架技術的作用

由於生物材料科學、生物工程和智慧醫療技術的進步，塗層支架市場正在迅速發展。藥物釋放型塗層支架的引入透過降低血管再阻塞和血栓症的風險顯著改善了患者的預後。含有抗發炎和抗菌劑的奈米技術塗層進一步提高了支架性能並最大限度地減少了術後併發症。生物分解性和生物吸收支架的出現是血管治療的突破性進步；這些支架在達到治療目的後會逐漸溶解，消除了長期併發症。此外，人工智慧驅動的影像處理和機器人輔助導管插入技術正在提高支架放置的準確性並降低手術風險。智慧支架與嵌入式感測器的結合可以監測血流並即時檢測再血管再阻塞，這是另一個塑造市場的突破。 3D 列印技術可根據患者客製化支架，以提高血管相容性，進一步支援個人化醫療方法。

是什麼推動了覆膜支架市場的成長？關鍵市場促進因素說明

覆膜支架市場的成長受到多種因素的推動，包括心血管疾病盛行率的上升、支架設計技術的進步以及微創手術的日益普及。新興經濟體醫療基礎設施的不斷擴張，提高了介入性心臟病治療的可近性，進一步推動了市場需求。優惠的報銷政策和旨在減輕心血管疾病負擔的政府措施也推動了覆膜支架的普及。此外，越來越多針對下一代支架技術的臨床試驗正在刺激創新，從而開發出更安全、更有效的設備。由於成本效益高和恢復時間短，人們越來越傾向於門診病人手術，這也進一步推動了市場的發展。支架材料、數位健康整合和個人化血管解決方案的不斷進步預計將推動全球覆膜支架市場的持續成長，從而改善患者預後並提高醫療效率。

部分

產品（血管支架、非血管支架）、最終使用者（醫院最終使用者、門診醫療中心最終使用者、專科診所最終使用者）

受訪公司範例

  • Abbott Laboratories
  • Alvimedica
  • AndraTec GmbH
  • Artivion, Inc.
  • B. Braun Interventional Systems, Inc.
  • BD Interventional
  • Bentley InnoMed GmbH
  • Biosensors International Group, Ltd.
  • Biotronik AG
  • Boston Scientific Corporation
  • Cook Medical
  • Cordis（a Cardinal Health company）
  • Getinge AB
  • Gore Medical（WL Gore & Associates）
  • iVascular SLU
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP30275

Global Covered Stents Market to Reach US$1.4 Billion by 2030

The global market for Covered Stents estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Vascular Stent, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$991.7 Million by the end of the analysis period. Growth in the Non-vascular Stent segment is estimated at 1.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$310.9 Million While China is Forecast to Grow at 6.3% CAGR

The Covered Stents market in the U.S. is estimated at US$310.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$275.9 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Covered Stents Market - Key Trends & Drivers Summarized

Why Are Covered Stents Gaining Widespread Adoption? Examining the Surge in Cardiovascular Interventions

The global covered stents market has witnessed significant growth due to the rising prevalence of cardiovascular diseases, peripheral artery disease (PAD), and aneurysms. With an increasing number of patients requiring minimally invasive vascular interventions, covered stents have emerged as a critical medical device, offering superior protection against restenosis and vessel rupture. The growing aging population, which is more susceptible to arterial blockages and aneurysms, has further fueled market demand. Additionally, advancements in stent technology, including drug-eluting and bioresorbable covered stents, have enhanced treatment outcomes, making these devices a preferred choice among interventional cardiologists. The shift from open surgeries to catheter-based interventions has driven market expansion, as covered stents provide a less invasive alternative for complex vascular procedures. Rising awareness regarding early diagnosis and treatment of arterial diseases, coupled with an increase in healthcare expenditures, has also played a pivotal role in the market’s growth. Government initiatives promoting cardiovascular health, along with increased screening programs, have further accelerated the adoption of covered stents.

What Are the Leading Types of Covered Stents? Analyzing Market Segmentation by Material & Application

The covered stents market is categorized based on material composition, design, and application, each catering to specific medical requirements. PTFE (polytetrafluoroethylene) and ePTFE-covered stents are among the most widely used due to their biocompatibility, flexibility, and ability to minimize restenosis. Another dominant category is polyurethane-covered stents, known for their durability and ability to resist thrombus formation. In terms of applications, covered stents are extensively used in cardiovascular procedures, particularly in treating aortic aneurysms and coronary artery disease. Peripheral vascular applications, including the treatment of carotid and femoral arteries, have also witnessed increased adoption. Additionally, covered stents play a vital role in endoscopic interventions, particularly for managing bile duct obstructions and gastrointestinal tract diseases. The development of self-expanding and balloon-expandable covered stents has further diversified treatment options, allowing physicians to select the most appropriate device based on patient-specific vascular conditions. The rising adoption of hybrid stent designs, which combine metal scaffolding with bioresorbable polymer coatings, has also contributed to market growth.

How Is Innovation Driving the Future of Covered Stents? The Role of Bioengineering & Smart Stent Technologies

The covered stents market is rapidly evolving, driven by advancements in biomaterial science, bioengineering, and smart medical technologies. The introduction of drug-eluting covered stents has significantly improved patient outcomes by reducing the risk of restenosis and thrombosis. Nanotechnology-based coatings, including anti-inflammatory and antimicrobial agents, have further enhanced stent performance, minimizing post-procedural complications. The emergence of biodegradable and bioresorbable stents represents a breakthrough in vascular treatment, as these stents gradually dissolve after fulfilling their therapeutic purpose, eliminating long-term complications. Additionally, AI-powered imaging and robotic-assisted catheterization techniques have improved precision in stent placement, reducing procedural risks. The integration of smart stents with embedded sensors capable of monitoring blood flow and detecting restenosis in real-time is another revolutionary advancement shaping the market. Personalized medicine approaches are also gaining traction, with 3D printing technology enabling patient-specific stent customization for enhanced vascular compatibility.

What’s Fueling the Growth of the Covered Stents Market? Key Market Drivers Explained

The growth in the covered stents market is driven by several factors, including the rising prevalence of cardiovascular diseases, technological advancements in stent design, and increasing adoption of minimally invasive procedures. The expansion of healthcare infrastructure in emerging economies has improved access to interventional cardiology treatments, further propelling market demand. Favorable reimbursement policies and government initiatives aimed at reducing the burden of cardiovascular diseases have also encouraged the adoption of covered stents. Additionally, the growing number of clinical trials focused on next-generation stent technologies has fueled innovation, leading to the development of safer and more effective devices. The increasing preference for outpatient procedures, driven by cost-effectiveness and faster recovery times, has further expanded the market. With continuous advancements in stent materials, digital health integration, and personalized vascular solutions, the global covered stents market is expected to witness sustained growth, offering improved patient outcomes and enhanced healthcare efficiency.

SCOPE OF STUDY:

The report analyzes the Covered Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Vascular Stent, Non-vascular Stent); End-Use (Hospitals End-Use, Ambulatory Care Centers End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Alvimedica
  • AndraTec GmbH
  • Artivion, Inc.
  • B. Braun Interventional Systems, Inc.
  • BD Interventional
  • Bentley InnoMed GmbH
  • Biosensors International Group, Ltd.
  • Biotronik AG
  • Boston Scientific Corporation
  • Cook Medical
  • Cordis (a Cardinal Health company)
  • Getinge AB
  • Gore Medical (W. L. Gore & Associates)
  • iVascular S.L.U.
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Covered Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Diseases Propels Demand for Covered Stents in Vascular Interventions
    • Technological Advancements in Biocompatible Materials Strengthen the Business Case for Enhanced Covered Stents
    • Increasing Adoption of Minimally Invasive Procedures Expands Addressable Market for Covered Stents in Treatment Protocols
    • Growing Focus on Long-Term Durability and Reduced Re-Stenosis Rates Drives Demand for High-Performance Covered Stents
    • Surge in Diabetic and Aging Populations Accelerates Market Growth for Covered Stents in Peripheral Artery Disease (PAD) Treatment
    • Regulatory Approvals for New Covered Stent Designs Accelerate Market Penetration and Adoption
    • Demand for Customizable, Patient-Specific Stent Solutions Expands Opportunity for Tailored Covered Stent Technologies
    • Advances in Coating Technologies Drive Adoption of Drug-Eluting Covered Stents, Expanding Treatment Options
    • Increasing Focus on Global Healthcare Access and Affordability Strengthens Market for Cost-Effective Covered Stent Solutions
    • Expansion of Hybrid Procedures Combining Stent Implants with Other Therapeutic Interventions Generates New Market Opportunities
    • Rising Number of Coronary Artery Bypass Surgeries Strengthens Growth for Covered Stents as an Alternative to Traditional Surgery
    • Emergence of Hybrid Stent Materials Drives Innovation in Multi-Layered Covered Stents with Enhanced Healing Properties
    • Regulatory Pressure to Improve Post-Surgery Outcomes Drives Innovation in Stent Coatings and Bio-Absorbable Technologies
    • Increasing Number of Healthcare Institutions Investing in Advanced Cardiovascular Technologies Expands Market Reach
    • Rising Global Health Awareness and Preventative Care Initiatives Drive Early Adoption of Covered Stents for At-Risk Populations
    • Competition in the Medical Device Industry Stimulates Innovation in Covered Stent Designs to Meet Evolving Clinical Needs
    • Rising Incidence of Complex Aortic and Endovascular Diseases Spurs Demand for Specialized Covered Stent Solutions
    • Integration of Artificial Intelligence in Medical Imaging and Procedure Planning Enhances Adoption of Covered Stents in Precision Medicine
    • Surge in Clinical Research and Trials for Covered Stents Expands Market Understanding and Adoption of New Treatments
    • Focus on Reducing Healthcare Costs and Improving Patient Outcomes Drives Growth of Covered Stents with Shorter Recovery Times and Fewer Complications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Covered Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vascular Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vascular Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Vascular Stent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-vascular Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-vascular Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Non-vascular Stent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Care Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Care Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Care Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Covered Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Covered Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Covered Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Covered Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION